Fig. 6
From: Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Primary therapies targeting MDSCs. MDSCs are eliminated, and/or their immunosuppressive activity is inhibited by different strategies, including (1) depletion of MDSCs populations, (2) inhibition of MDSCs recruitment, (3) inhibition of MDSCs immunosuppressive activity, and (4) induction of MDSCs differentiation